tiprankstipranks
Trending News
More News >
Biomarin Pharmaceutical Inc. (DE:BM8)
NASDAQ:BM8

Compare BioMarin Pharmaceutical (BM8) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
BioMarin Pharmaceutical
€47.13
€9.09B
32.67
-28.24%
13 Buy
3 Hold
0 Sell
Strong Buy
Jazz Pharmaceuticals
$180.62
$11.22B
12.74
31.39%
12 Buy
0 Hold
0 Sell
Strong Buy
PTC Therapeutics
$65.30
$5.50B
8.85
16.24%
8 Buy
3 Hold
0 Sell
Moderate Buy
Ultragenyx Pharmaceutical
$20.27
$1.96B
-3.94
-48.26%
20 Buy
1 Hold
0 Sell
Strong Buy
Summit Therapeutics
$15.51
$12.10B
-14.92
-21.01%
8 Buy
2 Hold
0 Sell
Strong Buy
Immunovant
$22.98
$4.96B
-10.43
24.13%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:BM8
BioMarin Pharmaceutical
47.13
-19.75
-29.53%
JAZZ
Jazz Pharmaceuticals
182.32
40.30
28.38%
PTCT
PTC Therapeutics
66.42
9.39
16.47%
RARE
Ultragenyx Pharmaceutical
20.27
-19.09
-48.50%
SMMT
Summit Therapeutics
15.60
-5.09
-24.60%
IMVT
Immunovant
24.38
4.94
25.41%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts